Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
CMS is aiming for robust Part D plan participation in the BALANCE model, which is voluntary for plans, but this is still uncertain
Dramatic weight loss at that scale creates real, predictable changes to the body's appearance that are worth understanding before you begin treatment
Epub 2023 Oct 10
Retatrutide remains under clinical investigation and has not yet received regulatory approval, with ongoing Phase 3 trials evaluating long-term safety and effectiveness
Document everything with your doctor
US$ 20.69
US$ 21.45
US$ 24.26
US$ 29.52
US$ 28.58
